Xylem Inc. (NYSE:XYL) Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC cut its stake in Xylem Inc. (NYSE:XYLFree Report) by 3.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,898 shares of the industrial products company’s stock after selling 3,062 shares during the period. Calamos Advisors LLC’s holdings in Xylem were worth $11,379,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in XYL. EverSource Wealth Advisors LLC raised its stake in shares of Xylem by 68.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after buying an additional 77 shares in the last quarter. Blue Trust Inc. raised its position in Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC lifted its holdings in Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares during the last quarter. Hazlett Burt & Watson Inc. boosted its position in shares of Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 220 shares in the last quarter. Finally, Spire Wealth Management grew its stake in shares of Xylem by 370.9% in the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock worth $54,000 after purchasing an additional 382 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

XYL has been the topic of several recent research reports. Oppenheimer lifted their price target on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. UBS Group began coverage on Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target for the company. TD Cowen lifted their target price on shares of Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a research report on Thursday, June 6th. Stifel Nicolaus raised their price target on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Finally, Argus boosted their target price on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 29th. Five equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $147.54.

Get Our Latest Stock Analysis on XYL

Insider Buying and Selling at Xylem

In other news, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the transaction, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Xylem Stock Performance

Shares of NYSE XYL opened at $136.92 on Monday. The business’s 50-day simple moving average is $135.11 and its 200-day simple moving average is $133.15. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85. The firm has a market cap of $33.20 billion, a price-to-earnings ratio of 48.73, a P/E/G ratio of 2.39 and a beta of 1.04.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company’s quarterly revenue was up 26.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 earnings per share. As a group, equities research analysts expect that Xylem Inc. will post 4.25 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th will be given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Thursday, August 29th. Xylem’s dividend payout ratio is 51.25%.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.